Key facts
- Centaur.ai’s last known valuation is $70.4M.
- It has raised $32.0M across 2 recorded rounds; the latest was Later Stage VC (Series B) ($16.0M) in Oct 2024.
- Notable investors include Y Combinator, Alumni Ventures, Accel, Matrix, Global Founders Capital — 30 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Centaur.ai
Funding rounds
2 roundsAbout Centaur.ai
Provider of medical data annotation services intended to offer assistance with medical decisions and diagnosis. The company's platform offers medical decision-making through medical data labeling and analyzes medical cases as they help to build the next generation of medical AI, enabling patients to reduce costs and have improved healthcare outcomes.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2017
- Employees
- 34
- Website
- centaur.ai/
- Ownership
- Privately Held (backing)
Centaur.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Centaur.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Centaur.ai in its N-PORT filings yet. We sweep new filings monthly.